Cite
HARVARD Citation
Truman, L. et al. (2015). Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study. BMJ open. 5 (12), p. . [Online].